Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Ataciguat (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator.
Description | Ataciguat (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator. |
In vitro | Ataciguat induces the relaxation in aortic rings or coronary rings. In the presence of nitric oxide synthase (NOS) inhibitor, the endothelium effect was abolished to DETA-NO or ataciguat, in both vessels. Ataciguat was able to induce NO production in HUVECs cells. In the presence of NOS inhibitor, the NO production induced by ataciguat was abolished[1]. |
Synonyms | HMR-1766 |
Molecular Weight | 576.48 |
Formula | C21H19Cl2N3O6S3 |
CAS No. | 254877-67-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 95mg/mL (164.79 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ataciguat 254877-67-3 G蛋白偶联受体 其他 Guanylate cyclase Others cyclase soluble HMR 1766 Guanylate Cyclase Inhibitor sGC HMR-1766 inhibit HMR1766 vasodilator cGMP guanylate inhibitor